Safety and Efficacy of First-Line Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC)

Authors

Keywords

Journal

Volume 90, Issue 5, Pages S32-S33

Publisher

Elsevier BV

Online

2014-10-30

DOI

10.1016/j.ijrobp.2014.08.207

Explore over 38,000 international journals covering a vast array of academic fields.

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now